<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.340">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>diseases-of-the-myelin-and-metabolic-and-toxic-disorders-</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/clipboard/clipboard.min.js"></script>
<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/quarto.js"></script>
<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/popper.min.js"></script>
<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/tippy.umd.min.js"></script>
<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/anchor.min.js"></script>
<link href="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/bootstrap/bootstrap.min.js"></script>
<link href="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="diseases-of-the-myelin-and-metabolic-and-toxic-disorders-_files/libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">


</head>

<body class="fullcontent">

<div id="quarto-content" class="page-columns page-rows-contents page-layout-article">

<main class="content" id="quarto-document-content">



<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B10.jpg" class="img-fluid"></p>
<section id="diseases-of-the-myelin-metabolic-and-toxic-disorders" class="level1">
<h1>Diseases of the Myelin, Metabolic and Toxic Disorders</h1>
</section>
<section id="serdar-balci-md" class="level1">
<h1>Serdar BALCI, MD</h1>
</section>
<section id="primary-diseases-of-myelin" class="level1">
<h1>PRIMARY DISEASES OF MYELIN</h1>
</section>
<section id="myelin" class="level1">
<h1>Myelin</h1>
<p><strong>Axons are tightly ensheathed by myelin</strong></p>
<p><strong>Electrical insulator that allows rapid propagation of neural impulses</strong></p>
<p><strong>Consists of multiple layers of highly specialized, closely apposed plasma membranes</strong></p>
<p><strong>Assembled by oligodendrocytes</strong></p>
<p><strong>Myelinated axons are present in all areas of the brain</strong></p>
<p><strong>Dominant component in the white matter</strong></p>
<p><strong>Diseases of myelin are primarily white matter disorders</strong></p>
<p><strong>Most diseases of CNS myelin do not involve the peripheral nerves to any significant extent, and vice versa</strong></p>
</section>
<section id="myelin-in-peripheral-nerves" class="level1">
<h1>Myelin in peripheral nerves</h1>
<ul>
<li><strong>Differences of myelin in the CNS and PNS</strong></li>
<li><strong>Peripheral myelin is made by Schwann cells, not oligodendrocytes</strong></li>
<li><strong>Each Schwann cell in a peripheral nerve provides myelin for only one internode</strong>
<ul>
<li><strong>in the CNS, many internodes are created by processes coming from a single oligodendrocyte</strong></li>
</ul></li>
<li><strong>Specialized proteins and lipids are also different</strong></li>
<li><strong>Most diseases of CNS myelin do not involve the peripheral nerves to any significant extent, and vice versa</strong></li>
</ul>
</section>
<section id="diseases-involving-myelin" class="level1">
<h1>Diseases involving myelin</h1>
<ul>
<li><strong>Demyelinating diseases of the CNS</strong>
<ul>
<li><strong>Acquired conditions</strong></li>
<li><strong>Preferential damage to previously normal myelin</strong></li>
<li><strong>Most common diseases in this group result from immune-mediated injury</strong>
<ul>
<li><strong>multiple sclerosis (MS) and related disorders</strong></li>
</ul></li>
<li><strong>Viral infection of oligodendrocytes</strong>
<ul>
<li><strong>multifocal leukoencephalopathy</strong></li>
</ul></li>
<li><strong>injury caused by drugs and other toxic agents</strong></li>
</ul></li>
<li><strong>Dysmyelinating diseases (Leukodystrophy)</strong>
<ul>
<li><strong>Myelin is not formed properly</strong></li>
<li><strong>Has abnormal turnover kinetics</strong></li>
<li><strong>Mutations that disrupt the function of proteins that are required for the formation of normal myelin sheaths</strong></li>
</ul></li>
</ul>
</section>
<section id="demyelinating-diseases" class="level1">
<h1>DEMYELINATING DISEASES</h1>
</section>
<section id="multiple-sclerosis" class="level1">
<h1>Multiple Sclerosis</h1>
<ul>
<li><p><strong>Autoimmune demyelinating disorder</strong></p></li>
<li><p><strong>Distinct episodes of neurologic deficits, separated in time, attributable to white matter lesions that are separated in space</strong></p></li>
<li><p><strong>Most common demyelinating disorder</strong></p>
<ul>
<li><strong>1/1000 persons in most of the United States and Europe</strong></li>
</ul></li>
<li><p><strong>May become clinically apparent at any age</strong></p>
<ul>
<li><strong>onset in childhood or &gt;50 is rare</strong></li>
</ul></li>
<li><p><strong>F:M=2:1</strong></p></li>
<li><p><strong>Relapsing and remitting episodes of neurologic impairment</strong></p>
<ul>
<li><strong>frequency of relapses tends to decrease during the course of the illness</strong></li>
</ul></li>
<li><p><strong>A steady neurologic deterioration is characteristic in a subset of patients</strong></p></li>
<li><p><strong>Combination of environmental and genetic factors</strong></p></li>
<li><p><strong>Loss of tolerance to self myelin antigens</strong></p></li>
<li><p><strong>Initiating agent, an infectious agent?</strong></p></li>
<li><p><strong>15x higher when in first-degree relative</strong></p></li>
<li><p><strong>Concordance rate for monozygotic twins 25%</strong></p>
<ul>
<li><strong>much lower rate for dizygotic twins</strong></li>
</ul></li>
<li><p><strong>HLA-DR2 most significantly increases the risk for developing MS</strong></p></li>
<li><p><strong>Polymorphisms in the genes cytokines IL-2 and IL-7</strong></p>
<ul>
<li><strong>activation and regulation of T cell–mediated immune responses</strong></li>
</ul></li>
</ul>
<p><strong>Prominent chronic inflammatory cells within and around MS plaques</strong></p>
<p><strong>Genetic evidence</strong></p>
<p><strong>→ Immune-mediated myelin destruction have a central role</strong></p>
<p><strong>Central role for CD4+ T cells</strong></p>
<p><strong>Increase in TH17 and TH1 CD4+ cells</strong></p>
<p><strong>CD8+ T cells and B cells</strong></p>
<ul>
<li><strong>Sometimes axonal degeneration occurs</strong>
<ul>
<li><strong>Toxic effects of lymphocytes, macrophages, and their secreted molecules</strong></li>
<li><strong>May cause neuronal death</strong></li>
</ul></li>
</ul>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B11.png" class="img-fluid"></p>
<p><strong>Multiple Sclerosis</strong></p>
<p><strong>White matter disease</strong></p>
<p><strong>Affected areas showing multiple, well-circumscribed, slightly depressed, glassy-appearing, gray-tan, irregularly shaped lesions</strong></p>
<p><strong>Plaques</strong></p>
<p><strong>Commonly arise near the ventricles</strong></p>
<p><strong>Frequent in the optic nerves and chiasm, brain stem, ascending and descending fiber tracts, cerebellum, and spinal cord</strong></p>
<p><span style="color:#FFFFFF">Robbins Basic Pathology</span></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B12.png" class="img-fluid"></p>
<p><strong>Multiple Sclerosis</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Sharply defined borders</strong></p>
<ul>
<li><strong>Active plaque</strong>
<ul>
<li><strong>Ongoing myelin breakdown</strong></li>
<li><strong>Abundant macrophages containing myelin debris</strong></li>
<li><strong>Lymphocytes and macrophages are present</strong></li>
<li><strong>Perivascular cuffs</strong></li>
<li><strong>Small active lesions often are centered on small veins</strong></li>
<li><strong>Axons are relatively preserved but may be reduced in number</strong></li>
</ul></li>
<li><strong>Active plaque</strong></li>
<li><strong>Four classes, only one is seen in affected patient</strong>
<ul>
<li><strong>Type I</strong>
<ul>
<li><strong>macrophage infiltrates with sharp margins</strong></li>
</ul></li>
<li><strong>Type II</strong>
<ul>
<li><strong>Similar to type I</strong></li>
<li><strong>also complement deposition (antibody-mediated component)</strong></li>
</ul></li>
<li><strong>Type III</strong>
<ul>
<li><strong>Less well-defined borders</strong></li>
<li><strong>Oligodendrocyte apoptosis</strong></li>
</ul></li>
<li><strong>Type IV</strong>
<ul>
<li><strong>Nonapoptotic oligodendrocyte loss</strong></li>
</ul></li>
</ul></li>
<li><strong>Inactive plaques</strong>
<ul>
<li><strong>Inflammation mostly disappears</strong></li>
<li><strong>Little, no myelin</strong></li>
<li><strong>Astrocytic proliferation and gliosis are prominent</strong></li>
</ul></li>
</ul>
</section>
<section id="clinical-course-of-ms" class="level1">
<h1>Clinical course of MS</h1>
<p><strong>The clinical course is variable</strong></p>
<p><strong>Multiple relapses followed by episodes of remission</strong></p>
<p><strong>Recovery during remissions is not complete</strong></p>
<p><strong>Over time there is usually a gradual, often stepwise, accumulation of neurologic deficits</strong></p>
<p><strong>Imaging studies have demonstrated that there are often more lesions in the brains of patients with MS than might be expected from the clinical examination</strong></p>
<p><strong>Lesions can come and go much more often than was previously suspected</strong></p>
<ul>
<li><strong>Changes in cognitive function can be present</strong>
<ul>
<li><strong>Much milder than the other deficits</strong></li>
</ul></li>
<li><strong>It is hard to predict when the next relapse will occur</strong></li>
<li><strong>CSF examination</strong>
<ul>
<li><strong>A mildly elevated protein level</strong></li>
<li><strong>Increased proportion of immunoglobulin</strong>
<ul>
<li><strong>Oligoclonal bands</strong></li>
<li><strong>Antibodies are directed against a variety of antigenic targets</strong></li>
</ul></li>
<li><strong>1/3 moderate pleocytosis</strong></li>
</ul></li>
</ul>
</section>
<section id="other-acquired-demyelinating-diseases" class="level1">
<h1>Other Acquired Demyelinating Diseases</h1>
<ul>
<li><strong>Immune-mediated demyelination after systemic infectious illnesses</strong>
<ul>
<li><strong>even mild viral diseases</strong></li>
</ul></li>
<li><strong>Not related to direct spread of the infectious agents to the nervous system</strong>
<ul>
<li><strong>Immune cells responding to pathogen-associated antigens cross react against myelin antigens → myelin damage</strong></li>
</ul></li>
</ul>
</section>
<section id="postinfectious-autoimmune-reactions-to-myelin" class="level1">
<h1>Postinfectious autoimmune reactions to myelin</h1>
<ul>
<li><strong>Associated with acute-onset monophasic illnesses</strong></li>
<li><strong>Acute disseminated encephalomyelitis</strong>
<ul>
<li><strong>Symptoms typically develop a week or two after an antecedent infection</strong></li>
<li><strong>Nonlocalizing (headache, lethargy, and coma)</strong>
<ul>
<li><strong>In contrast with the focal findings of MS</strong></li>
</ul></li>
<li><strong>Symptoms progress rapidly</strong></li>
<li><strong>Fatal in 20% of cases</strong></li>
<li><strong>Others recover completely</strong></li>
</ul></li>
<li><strong>Acute necrotizing hemorrhagic encephalomyelitis</strong>
<ul>
<li><strong>More devastating disorder</strong></li>
<li><strong>Typically affects young adults and children</strong></li>
</ul></li>
</ul>
</section>
<section id="neuromyelitis-optica" class="level1">
<h1>Neuromyelitis optica</h1>
<p><strong>Inflammatory demyelinating disease</strong></p>
<p><strong>Centered on the optic nerves and spinal cord</strong></p>
<p><strong>Antibody-mediated autoimmune disorder</strong></p>
<p><strong>Antibodies to the water channel aquaporin-4 are both diagnostic and pathogenic</strong></p>
</section>
<section id="central-pontine-myelinolysis" class="level1">
<h1>Central pontine myelinolysis</h1>
<ul>
<li><strong>Nonimmune process</strong></li>
<li><strong>Loss of myelin involving the center of the pons</strong></li>
<li><strong>Rapid correction of hyponatremia</strong></li>
<li><strong>Mechanism of oligodendroglial cell injury is uncertain</strong></li>
<li><strong>May be related to edema induced by sudden changes in osmotic pressure</strong></li>
<li><strong>Alcoholism and severe electrolyte or osmolar imbalance</strong></li>
<li><strong>Similar lesions can be found elsewhere in the brain</strong></li>
<li><strong>Involvement of fibers in the pons</strong>
<ul>
<li><strong>rapidly evolving quadriplegia</strong></li>
</ul></li>
</ul>
</section>
<section id="progressive-multifocal-leukoencephalopathy" class="level1">
<h1>Progressive multifocal leukoencephalopathy</h1>
<p><strong>Demyelinating disease</strong></p>
<p><strong>Occurs after reactivation of JC virus in immunosuppressed patients</strong></p>
</section>
<section id="dysmyelinating-diseases-leukodystrophy" class="level1">
<h1>DYSMYELINATING DISEASES (LEUKODYSTROPHY)</h1>
</section>
<section id="leukodystrophies" class="level1">
<h1>Leukodystrophies</h1>
<p><strong>Inherited dysmyelinating diseases</strong></p>
<p><strong>Clinical symptoms derive from abnormal myelin synthesis or turnover</strong></p>
<p><strong>Lysosomal enzymes</strong></p>
<p><strong>Peroxisomal enzymes</strong></p>
<p><strong>Mutations in myelin proteins</strong></p>
<p><strong>Most are autosomal recessive inheritance</strong></p>
<p><strong>X-linked diseases also occur</strong></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B13.png" class="img-fluid"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>
<section id="morphology-of-leukodystrophy" class="level1">
<h1>Morphology of leukodystrophy</h1>
<ul>
<li><strong>Changes in white matter</strong></li>
<li><strong>Diffusely change in color (gray and translucent)</strong></li>
<li><strong>Volume is decreased</strong></li>
<li><strong>Early in their course</strong>
<ul>
<li><strong>Some diseases may show patchy involvement</strong></li>
<li><strong>Others have a predilection for occipital lobe involvement</strong></li>
</ul></li>
<li><strong>End</strong>
<ul>
<li><strong>Nearly all of the white matter usually is affected</strong></li>
<li><strong>Loss of white matter</strong></li>
<li><strong>Brain becomes atrophic</strong></li>
<li><strong>Ventricles enlarge</strong></li>
<li><strong>Secondary changes can be found in the gray matter</strong></li>
</ul></li>
<li><strong>Myelin loss</strong></li>
<li><strong>Infiltration of macrophages</strong>
<ul>
<li><strong>stuffed with lipid</strong></li>
</ul></li>
<li><strong>Specific inclusions created by the accumulation of particular lipids</strong></li>
</ul>
</section>
<section id="clinical-features-of-leukodystrophies" class="level1">
<h1>Clinical Features of Leukodystrophies</h1>
<ul>
<li><strong>Each leukodystrophy has a characteristic clinical presentation</strong></li>
<li><strong>Most can be diagnosed by genetic or biochemical methods</strong></li>
<li><strong>Despite differences in underlying mechanisms share many features because of the common myelin target</strong></li>
<li><strong>Affected children are normal at birth</strong>
<ul>
<li><strong>Begin to miss developmental milestones during infancy and childhood</strong></li>
</ul></li>
<li><strong>Diffuse involvement of white matter</strong>
<ul>
<li><strong>Deterioration in motor skills</strong></li>
<li><strong>Spasticity, hypotonia, or ataxia</strong></li>
</ul></li>
<li><strong>The earlier the age at onset, the more severe the deficiency and clinical course</strong></li>
</ul>
</section>
<section id="acquired-metabolic-and-toxic-disturbances" class="level1">
<h1>ACQUIRED METABOLIC AND TOXIC DISTURBANCES</h1>
</section>
<section id="acquired-metabolic-and-toxic-disturbances-1" class="level1">
<h1>Acquired Metabolic and Toxic Disturbances</h1>
<ul>
<li><strong>Relatively common causes of neurologic illnesses</strong></li>
<li><strong>Brain is particularly vulnerable to nutritional diseases and alterations in metabolic state</strong>
<ul>
<li><strong>High metabolic demands</strong></li>
<li><strong>Unique features or requirements of different anatomic regions</strong>
<ul>
<li><strong>Effects are not global</strong></li>
</ul></li>
</ul></li>
<li><strong>Nutritional Diseases</strong>
<ul>
<li><strong>Thiamine Deficiency</strong></li>
<li><strong>Vitamin B Deficiency</strong></li>
</ul></li>
<li><strong>Metabolic Disorders</strong>
<ul>
<li><strong>Hypoglycemia</strong></li>
<li><strong>Hyperglycemia</strong></li>
<li><strong>Hepatic Encephalopathy</strong></li>
</ul></li>
<li><strong>Toxic Disorders</strong></li>
</ul>
</section>
<section id="thiamine-deficiency" class="level1">
<h1>Thiamine Deficiency</h1>
<ul>
<li><strong>Wernicke encephalopathy</strong></li>
<li><strong>Abrupt onset of confusion</strong></li>
<li><strong>Abnormalities in eye movement</strong></li>
<li><strong>Ataxia</strong></li>
<li><strong>Treatment with thiamine can reverse deficits</strong></li>
<li><strong>If acute stages go untreated</strong>
<ul>
<li><strong>Irreversible profound memory disturbances</strong></li>
<li><strong>Korsakoff syndrome</strong></li>
</ul></li>
</ul>
</section>
<section id="wernicke-korsakoff-syndrome" class="level1">
<h1>Wernicke-Korsakoff syndrome</h1>
<ul>
<li><p><strong>Chronic alcoholism</strong></p></li>
<li><p><strong>Gastric disorders</strong></p>
<ul>
<li><strong>Carcinoma</strong></li>
<li><strong>Chronic gastritis</strong></li>
<li><strong>Persistent vomiting</strong></li>
</ul></li>
<li><p><strong>Foci of hemorrhage and necrosis</strong></p>
<ul>
<li><strong>Mammillary bodies</strong></li>
<li><strong>Adjacent to the ventricles</strong></li>
<li><strong>Third and fourth ventricles</strong></li>
</ul></li>
<li><p><strong>Despite the presence of necrosis, relative preservation of many of the neurons</strong></p></li>
<li><p><strong>Early lesions</strong></p>
<ul>
<li><strong>Dilated capillaries with prominent endothelial cells and progress to hemorrhage</strong></li>
</ul></li>
<li><p><strong>As lesions resolve</strong></p>
<ul>
<li><strong>Cystic space appears along with hemosiderin-laden macrophages</strong></li>
</ul></li>
<li><p><strong>Lesions in the medial dorsal nucleus of the thalamus best correlate with the memory disturbance in Korsakoff syndrome</strong></p></li>
</ul>
</section>
<section id="vitamin-b-deficiency" class="level1">
<h1>Vitamin B Deficiency</h1>
<p><strong>Pernicious anemia</strong></p>
<p><strong>Neurologic deficits associated with changes in the spinal cord</strong></p>
<p><strong>Subacute combined degeneration of the spinal cord</strong></p>
<p><strong>Both ascending and descending tracts of the spinal cord are affected</strong></p>
<p><strong>Symptoms develop over weeks</strong></p>
<ul>
<li><strong>Early clinical signs</strong>
<ul>
<li><strong>Slight ataxia</strong></li>
<li><strong>Lower extremity numbness and tingling</strong></li>
</ul></li>
<li><strong>Progress to</strong>
<ul>
<li><strong>Spastic weakness of the lower extremities</strong></li>
<li><strong>Complete paraplegia ensues</strong></li>
</ul></li>
<li><strong>Prompt vitamin replacement therapy produces clinical improvement</strong></li>
<li><strong>If paraplegia has developed, recovery is poor</strong></li>
</ul>
</section>
<section id="hypoglycemia" class="level1">
<h1>Hypoglycemia</h1>
<p><strong>Brain requires glucose as a substrate for energy production</strong></p>
<p><strong>Cellular effects of diminished glucose generally resemble those of global hypoxia</strong></p>
<p><strong>Hippocampal neurons are particularly susceptible to hypoglycemic injury</strong></p>
<p><strong>Cerebellar Purkinje cells are relatively spared</strong></p>
<p><strong>As with anoxia, if the level and duration of hypoglycemia are sufficiently severe, injury is widespread</strong></p>
</section>
<section id="hyperglycemia" class="level1">
<h1>Hyperglycemia</h1>
<ul>
<li><strong>Inadequately controlled diabetes mellitus</strong></li>
<li><strong>Ketoacidosis, hyperosmolar coma</strong></li>
<li><strong>Confusion, stupor, coma</strong></li>
<li><strong>Intracellular dehydration, hyperosmolar state</strong></li>
<li><strong>Hyperglycemia must be corrected gradually</strong>
<ul>
<li><strong>Rapid correction can produce severe cerebral edema</strong></li>
</ul></li>
</ul>
</section>
<section id="hepatic-encephalopathy" class="level1">
<h1>Hepatic Encephalopathy</h1>
<ul>
<li><strong>Decreased hepatic function</strong></li>
<li><strong>Depressed levels of consciousness and sometimes coma</strong></li>
<li><strong>Early stages</strong>
<ul>
<li><strong>“flapping” tremor (asterixis) when extending the arms with palms facing the observer</strong></li>
</ul></li>
<li><strong>Elevated levels of ammonia</strong>
<ul>
<li><strong>ammonia metabolism occurs only in astrocytes through the action of glutamine synthetase</strong></li>
<li><strong>hyperammonemia → astrocytes in the cortex and basal ganglia develop swollen, pale nuclei (called Alzheimer type II cells )</strong></li>
</ul></li>
</ul>
</section>
<section id="toxic-disorders" class="level1">
<h1>Toxic Disorders</h1>
<p><strong>Lead</strong></p>
<p><strong>Arsenic</strong></p>
<p><strong>Mercury</strong></p>
<p><strong>Organophosphates</strong></p>
<p><strong>Methanol</strong></p>
<p><strong>CO</strong></p>
<p><strong>Ethanol</strong></p>
<p><strong>Radiation</strong></p>
<ul>
<li><strong>Lead</strong>
<ul>
<li><strong>diffuse encephalopathy</strong></li>
</ul></li>
<li><strong>Arsenic</strong></li>
<li><strong>Mercury</strong></li>
<li><strong>Industrial chemicals</strong>
<ul>
<li><strong>organophosphates (in pesticides)</strong></li>
<li><strong>methanol (causing blindness from retinal damage)</strong></li>
<li><strong>carbon monoxide (combining hypoxia with selective injury to the globus pallidus)</strong></li>
</ul></li>
<li><strong>Ethanol</strong>
<ul>
<li><strong>Acute intoxication is reversible</strong></li>
<li><strong>Excessive intake can result in profound metabolic disturbances</strong>
<ul>
<li><strong>Brain swelling and death</strong></li>
</ul></li>
</ul></li>
<li><strong>Chronic alcohol exposure</strong>
<ul>
<li><strong>Cerebellar dysfunction</strong>
<ul>
<li><strong>Truncal ataxia</strong></li>
<li><strong>Unsteady gait</strong></li>
<li><strong>Nystagmus</strong></li>
<li><strong>Atrophy in the anterior vermis</strong></li>
</ul></li>
</ul></li>
<li><strong>Ionizing radiation</strong>
<ul>
<li><strong>rapidly evolving signs and symptoms</strong>
<ul>
<li><strong>headaches, nausea, vomiting, and papilledema</strong></li>
<li><strong>even months to years after irradiation</strong></li>
</ul></li>
<li><strong>Large areas of coagulative necrosis</strong></li>
<li><strong>Adjacent edema</strong></li>
<li><strong>Blood vessels with thickened walls containing intramural fibrin-like material</strong></li>
</ul></li>
</ul>
</section>
<section id="section" class="level1">
<h1></h1>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B14.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B15.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B16.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B17.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img src="img%5CDiseases-of-the-Myelin-and-Metabolic-and-Toxic-Disorderspptx-kopyas%C4%B18.png" class="img-fluid"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
</section>

</main>
<!-- /main column -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>